Viewing Option
China blood plasma products market is steadily growing from 2012 to more than double in 2017. It is anticipated that blood plasma products market in China will grow at a CAGR of 12.45 percent during the forecasting perio....
The global CAR-T Cell therapy market is anticipated to grow over 20 percent CAGR during the forecasting period and likely to touch nearly US$ 8 Billion landmarks in 2028. The year 2017 was the milestone year for the CAR-....